About Netbiz Dev

This author has not yet filled in any details.
So far Netbiz Dev has created 43 blog entries.

ActiveCare®+S.F.T. is a cost effective VTE prevention compared to Enoxaparin After Total Hip Arthroplasty

Cost-Effectiveness of Venous Thromboembolism Prophylaxis With a New Mobile Device After Total Hip Arthroplasty C. Colwell, M. Froimson, M. Mont, M. Ritter, R.Trousdale, K. Buehler, A. Spitzer, T. Donaldson, D. Padgett. The Journal of Arthroplasty, September 2012; 27(8):1417-1584 Findings: Based on the SAFE study, this model was constructed to evaluate any difference in cost-effectiveness between ActiveCare®+SFT and [...]

The use of ActiveCare® yields significant decrease in serious bleeding

Thrombosis Prevention after Total Hip Arthroplasty: A Prospective Randomized Trial Comparing a Mobile Compression Device with Low Molecular Weight Heparin C. Colwell, M. Froimson, M. Mont, M. Ritter, R.Trousdale, K. Buehler, A. Spitzer, T. Donaldson, D. Padgett. The Journal of Bone and Joint Surgery, March 2010; 92(3): 527-535 See link to abstract Main results: Efficacy:  There [...]

ActiveCare® treatment was at least 2 times more effective than enoxaparin in preventing DVT

DVT Prevention in Joint Arthroplasties: Continuous Enhanced Circulation Therapy vs. Low Molecular Weight Heparin Y. Gelfer, H. Tavor, A. Or on, A. Peer, N. Halperin, D. Robinson. The Journal of Arthroplasty, February 2006; 21(2): 206-214 Main results: Efficacy: The C.E.C.T protocol was significantly more effective than enoxaparin in reducing DVT Safety: Safety profiles were similar in [...]

ActiveCare® +enxoparin is more effective than IPC +enxoparin

Venous Thromboembolic Disease Reduction with a Portable Pneumatic Compression Device M. Froimson, T. Murray, A. Fazekas Journal of Arthroplasty February 2009; 24(2): 310-316 Main results: Efficacy: The replacement of the standard IPC by ActiveCare® reduced VTE rate from 3.6% to 1.3%. Length of Stay: The average LOS was shorter for patients treated with ActiveCare® than those treated with IPC (4.2 [...]

ActiveCare®+Enoxaparin (vs Enoxaparin) – reduces DVT rates

Portable Compression Device and LMWH Compared with LMWH for Thromboprophylaxis after Total Joint Arthroplasty J. Edwards, P. Pulido, K. Ezzet, S. Copp, R. Walker,  C. Colwell Journal of Arthroplasty, December 2008; 23(8): 1122-1127 Results: Efficacy: The addition of ActiveCare® to enoxaparin reduced the DVT rate from 12% to 4% (66% relative risk reduction). Safety: The safety profile remained unchanged. [...]

Multicenter study on 3060 patients finds ActiveCare® mobile compression device to be as effective as blood thinners without bleeding complications

A Mobile Compression Device for Thrombosis Prevention in Hip and Knee Arthroplasty C. Colwell, M. Froimson, M. Mont, M. Ritter, R. Trousdale, K. Buehler, A. Spitzer, T. Donaldson, D. Padgett. The Journal of Bone and Joint Surgery, Feb 2014, 05;96(3):177-183 Read lead article http://jbjs.org/content/96/3/177 Read the commentary written on the article http://jbjs.org/content/96/3/e23.full-text.pdf+html Findings:  Use of the mobile compression device [...]

February 2014

Activecare® gets professional recognition: Research on the device is published as a leading article in the most prestige journal JBJS. A special commentary is dedicated to this research in the Feb edition.  First Ever Large Scale Orthopedic Study Published in JBJS as Leading Article Approves the Change in How Patients are Treated to Prevent Deep Vein [...]

December 2013

When an Israeli company nears the sales stage, the debate whether it is time to hire an American CEO almost always begins. A man who knows the target market, has more experience in sales (very few Israeli managers of life sciences companies have reached this stage), and who can open doors. A well-known American CEO [...]

October 2013

Dr. Robert Barrack in the Charnley Lecture at 2013 BOA Annual Congress: “It is the First Time That the US Deep Vein Thrombosis (DVT) Prevention Guidelines Have Been Modified for the Interest of the Orthopedic Surgeons.”

September 2013

You can now follow us on Twitter for the most recent updates on DVT prevention in orthopedic surgery. MCS presents a new video for orthopedic surgeons.